What Has Marxism Got To Do With Transgender Ideology? | Emmet Connor
6 August 2026
With Emmet Connor
Global
Emmet Connor argues that gender ideology is one strand of a broader ideological project rooted in Marxist and Frankfurt School thought. For those examining why European health systems adopted gender-affirming protocols ahead of robust clinical evidence, his analysis of how ideology shapes institutional practice offers a critical lens — and context for understanding the wave of reviews and reversals now under way across the continent.
Emmet Connor is an Irish author and commentator whose book The Red Pandemic examines the ideological threads he believes run through many of today's most contested cultural movements. In this episode of Beyond Gender, Connor sets out his case that gender ideology does not exist in isolation but forms part of a broader project shaped by intellectual traditions stretching back to Marxist and Frankfurt School thought. The conversation pushes into uncomfortable territory — globalism, nationalism, identity politics — and Connor engages with sceptical questioning from the hosts throughout. At the centre of Connor's argument is the claim that the conceptual vocabulary of modern gender ideology — oppression, liberation, identity, the dismantling of fixed categories — did not emerge spontaneously. He traces it to a tradition of critical theory that reframed class struggle in cultural terms, replacing economic categories with those of identity. The Frankfurt School thinkers of the mid-twentieth century, he argues, built an intellectual architecture that later generations applied to sex, race and other axes of identity. This analysis raises questions that bear directly on how gender medicine came to be practised the way it has across Europe. That relevance is most visible in the institutional dimension. Gender-affirming care was adopted by health systems across much of Europe not primarily because randomised controlled trials demonstrated its safety and efficacy, but because international bodies issued guidelines that carried the prestige of authoritative consensus. Critics have argued that this consensus was built from a relatively closed expert network whose commitments preceded the evidence. If ideological frameworks shaped what counted as legitimate knowledge inside those networks, the pattern of rapid adoption followed by belated scrutiny becomes easier to understand. The systematic evidence reviews that have emerged in the past several years tell a consistent story. The Cass Review in England, and the reassessments conducted by health authorities in Sweden, Finland and Denmark, all found the evidence base for medical gender transition in minors to be methodologically weak and incapable of supporting the clinical confidence that had been projected. These reviews did not emerge from bad faith; they emerged from the ordinary requirements of evidence-based medicine being applied, belatedly, to a clinical field that had expanded rapidly under strong ideological impetus. Connor's analysis invites a further question: if the architecture of gender ideology is as he describes it, then meaningful policy reform requires more than updating clinical guidelines. It may require confronting the institutional and intellectual structures through which ideological commitments entered healthcare, education and law across Europe. That is a larger and more contested argument than any single evidence review can settle. But the episode offers a perspective that complements the clinical and legal record — a reminder that evidence does not speak for itself, and that the conditions under which evidence is sought, weighted and acted upon are themselves shaped by prior commitments.
